# Comparison: GLP-1 receptor agonists obesity cardiovascular outcomes randomized clinical trial

## Run metadata
- bsi-benchmark version: 0.1.0
- git commit: f2456653fcffff0c535025f5d23ef37d4b4d61e9
- run timestamp (UTC): 2026-08-11T19:51:12Z
- methodology: Scores/judgements come from an independent LLM judge (see comparison/judge.py) instructed not to reuse BSI's own D1-D7/EIG vocabulary and to choose its own evaluation criteria. If no judge model is available or its response cannot be parsed, the run falls back to a simple keyword-presence heuristic -- the stored record's own 'criteria_source' field ('llm' vs 'heuristic_fallback') always says honestly which one produced a given result. Neither path is a validated measurement of analytical quality until checked against independent human judgement on a representative sample.

> BSI prompt source: https://github.com/ibstrade11-source/behmanesh-index-prompt/blob/main/MASTER_PROMPT_BSI_v3.4.2.md

## Cardiovascular Outcomes with GLP-1 Receptor Agonists in Patients with Type 2 Diabetes or Obesity Undergoing Surgical Aortic Valve Replacement

*source:* https://doi.org/10.64898/2026.06.02.26354773
*doi:* 10.64898/2026.06.02.26354773

### Judge Evaluation

#### Judge Information

| Field | Value |
|---|---|
| Criteria source | llm |
| Score scale | 0-10 |
| Weight sum | 100.0 |

#### Judge Reasoning

**Winner:** raw

While both analyses capture the article’s main claims, the RAW analysis delivers clearer articulation of the research question, methodological considerations, and clinical interpretation. The BSI analysis adds structured tables and layered commentary but does not provide additional substantive evidence or deeper quantitative insight, resulting in a lower overall analytical quality.

#### Criteria Selected by Judge

| Criterion | Weight | Raw (/10) | BSI (/10) | Weighted Raw | Weighted BSI | Explanation |
|---|---:|---:|---:|---:|---:|---|
| Clarity of research question and hypothesis | 15 | 9.0 | 7.0 | 1.35 | 1.05 | The RAW analysis states the central question (effect of GLP‑1 RA on 1‑year cardiovascular outcomes after SAVR) in a concise, explicit sentence. The BSI analysis conveys the same idea but mixes Persian headings and a generic executive summary, making the question slightly less immediately clear. |
| Methodological rigor (cohort definition, confounding control) | 20 | 7.0 | 6.0 | 1.40 | 1.20 | RAW mentions a retrospective cohort of patients with T2DM or obesity undergoing SAVR and notes a 30‑day landmark analysis, implying some control for peri‑procedural bias. BSI lists a “quality methodology” score but provides no concrete details on inclusion criteria, propensity matching, or covariate adjustment, so its rigor is less demonstrable. |
| Quality of statistical analysis (hazard ratios, landmark analysis, adjustment) | 20 | 6.0 | 6.0 | 1.20 | 1.20 | Both analyses reference hazard ratios and a landmark restriction, indicating awareness of appropriate statistical techniques, but neither supplies the actual statistical model specifications, confidence intervals, or sensitivity analyses. Hence they receive equal moderate scores. |
| Interpretation of results and causal inference | 15 | 8.0 | 7.0 | 1.20 | 1.05 | RAW explicitly interprets the findings, distinguishes peri‑procedural vs. longer‑term effects, and cautions that randomized trials are needed before causal claims. BSI discusses implications and layered mechanisms but does not separate causation from association as clearly. |
| Acknowledgment of limitations and bias | 15 | 7.0 | 7.0 | 1.05 | 1.05 | Both analyses note key limitations: RAW highlights the observational design and need for prospective trials; BSI mentions sample size and methodological constraints. Their treatment of limitations is comparable. |
| Clinical relevance and applicability | 15 | 8.0 | 7.0 | 1.20 | 1.05 | RAW connects the findings to potential adjunctive peri‑operative cardioprotection and future clinical studies. BSI also points to clinical value but does so in a more generic manner without explicit translation to practice. |

#### Final Scores

| Analysis | Score (/10) |
|---|---:|
| Raw | 7.40 |
| BSI | 6.60 |

#### Summary

- Winner: **raw**
- Score difference: **-0.80**
- Criteria evaluated: **6**

#### Score Formula

Final score = Σ(weight × criterion score / 100)
